Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Video: Benefits of Additive Manufacturing for Tooling and Fixtures December 10, 2018 Maruti Suzuki unseats Mahindra as top utility vehicle maker in Q1 July 12, 2017 COPA-DATA introduces zenon 8.00 and zenon Analyzer 3.20 June 13, 2018